Company Evotec SE

Equities

EVT

DE0005664809

Biotechnology & Medical Research

Real-time Estimate Tradegate 09:27:09 2024-03-28 am EDT 5-day change 1st Jan Change
14.45 EUR +0.52% Intraday chart for Evotec SE +8.24% -32.07%

Business Summary

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women's health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Number of employees: 5,086

Sales per Business

EUR in Million2021Weight2022Weight Delta
EVT Execute
72.8 %
471 76.2 % 547 72.8 % +16.06%
EVT Innovate
27.2 %
147 23.8 % 205 27.2 % +39.29%

Sales per region

EUR in Million2021Weight2022Weight Delta
United States
55.7 %
338 54.6 % 418 55.7 % +23.90%
Rest of the World
16.9 %
98 15.9 % 127 16.9 % +28.85%
United Kingdom
15.3 %
105 16.9 % 115 15.3 % +10.15%
Germany
7.8 %
47 7.6 % 59 7.8 % +25.70%
France
4.3 %
31 4.9 % 32 4.3 % +5.50%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 19-06-18
Director of Finance/CFO 51 23-02-06
Chief Operating Officer 54 12-04-30
Chief Tech/Sci/R&D Officer 60 10-08-31
Public Communications Contact - -
Investor Relations Contact - -
Corporate Officer/Principal 51 22-04-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 61 19-06-18
Director/Board Member 56 19-06-18
Chairman 63 14-06-16
Director/Board Member 63 15-06-08
Director/Board Member 41 22-06-21
Director/Board Member 62 21-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 177,542,097 160,933,134 ( 90.65 %) 249,915 ( 0.1408 %) 90.65 %

Shareholders

NameEquities%Valuation
Novo Holdings A/S (Investment Company)
8.410 %
14,931,858 8.410 % 220 M €
Mubadala Investment Co. (Investment Company)
6.467 %
11,481,503 6.467 % 169 M €
T. Rowe Price International Ltd.
5.004 %
8,883,534 5.004 % 131 M €
2,904,146 1.636 % 43 M €
1,514,826 0.8532 % 22 M €
LBBW Asset Management Investmentgesellschaft mbH
0.7646 %
1,357,400 0.7646 % 20 M €
Fleming Family & Partners Capital Management LLP (Austria)
0.6308 %
1,120,000 0.6308 % 17 M €
Swedbank Robur Fonder AB
0.5599 %
994,000 0.5599 % 15 M €
Lupus alpha Asset Management AG
0.5424 %
963,000 0.5424 % 14 M €
Carmignac Gestion Luxembourg SA (UK)
0.5038 %
894,385 0.5038 % 13 M €
NameEquities%Valuation
Mubadala Investment Co. (Investment Company)
5.179 %
4,597,701 5.179 % 34 M €
Federated Global Investment Management Corp.
0.6499 %
576,933 0.6499 % 4 M €
Banque BPP SA
0.2704 %
240,000 0.2704 % 2 M €
Zürcher Kantonalbank (Investment Management)
0.1963 %
174,266 0.1963 % 1 M €
Millennium Management LLC
0.0973 %
86,385 0.0973 % 639 249 €
Optiver Holding BV
0.0910 %
80,810 0.0910 % 597 994 €
DCF Advisers LLC
0.0538 %
47,797 0.0538 % 353 698 €
Morgan Stanley Investment Management, Inc.
0.0492 %
43,707 0.0492 % 323 432 €
Pioneer Investments Austria GmbH
0.0475 %
42,168 0.0475 % 312 043 €
Cetera Investment Advisers LLC
0.0289 %
25,638 0.0289 % 189 721 €

Holdings

NameEquities%Valuation
14,035,200 11.86% 93,334,080 $

Company contact information

Evotec SE

Manfred Eigen Campus Essener Bogen 7

22419, Hamburg

+49 40 560 81 0

http://evotec.com
address Evotec SE(EVT)

Group companies

NameCategory and Sector
Miscellaneous Commercial Services
Pharmaceuticals: Major
Miscellaneous Commercial Services
Miscellaneous Commercial Services